1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

20 May 2024
Admin
News Article

Mankind Pharma launches 'Limit White India' Campaign for BP Awareness

Mankind Pharma launches 'Limit White India' Campaign to raise hypertension awareness

Overview

Mankind Pharma, the No.1 pharmaceutical company in the antihypertensive segment in India, as per MAT April’ 24 volume sale (Source: IQVIA) has launched a nationwide campaign on the occasion of World Hypertension Day called 'Limit White India'. This initiative aims to raise awareness about the dangers of excessive salt and sugar consumption which with other factors like sedentary lifestyle and obesity can be a major risk factor for hypertension.

Hypertension in India

Studies have shown that 1 in 4 adults in India suffer from hypertension and 101 million people in India which is about 11.4% of the country's population, are living with diabetes.
Diabetes and hypertension are often referred together as ""partners in crime"" due to their closely linked impact on global health.
It is common knowledge that these conditions not only coexist but exacerbate each other, creating a compounded risk of severe health issues such as cardiovascular diseases, stroke, and kidney failure.
The 'Limit White India' campaign focuses on educating Indians to limit their intake of 'whites' like salt and sugar.
The campaign emphasises the need for gradual lifestyle changes to improve cardiovascular health.
With the goal of driving a three-year awareness programme, Mankind Pharma aims to partner with healthcare professionals (HCPs) in the management of hypertension and diabetics across the country.

Words from CMO: Mankind

"Hypertension is a silent killer, and Mankind Pharma is committed to tackling it head-on through the 'Limit White India' campaign."" said Dr Sanjay Koul, chief marketing officer, Mankind Pharma Ltd.
"Excessive salt and sugar are significant contributors to uncontrolled blood pressure levels and blood sugar levels. Studies have shown Indians on average consume five times the WHO recommended quantity of sugar annually. By raising awareness and promoting lifestyle modifications, we aim to empower people to make informed choices for their well-being."

Campaign Strategy

As part of the campaign, Mankind Pharma will engage cardiologists, endocrinologists, diabetologists, general practitioners, and the public through educational initiatives.
These include conducting journal clubs, distributing 'Cardiac Cognizance' newsletters, radio awareness programmes with doctors, and blood pressure screening camps nationwide.

Mankind Pharma

Mankind Pharma is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence.
Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!